Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests

The tail suspension test: A new method for screening antidepressants in mice

Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · see citing works

Behavioral despair in mice: a primary screening test for antidepressants.

Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,275 · see citing works

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

Crawley, J. N., Belknap, J. K., Collins, A. C., Crabbe, J. C., Frankel, W. N., Henderson, N. D., HITZEMANN, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372 · see citing works

Dieting and binging: A causal analysis.

Polivy, J., & Herman, C. P. (1985) · American Psychologist · doi:10.1037//0003-066x.40.2.193 · Cited by 1,279 · see citing works

Smoking, smoking cessation, and major depression

Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207 · see citing works

Guidelines on nicotine dose selection for in vivo research

Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · see citing works

Smoking and Major Depression: A Causal Analysis

Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130038007 · Cited by 792 · see citing works

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785 · see citing works

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767 · see citing works

Different data from different labs: Lessons from studies of gene–environment interaction

Wahłsten, D., Metten, P., Phillips, T. J., Boehm, S. L., Burkhart‐Kasch, S., Dorow, J. D., Doerksen, S., Downing, C., Fogarty, J., Rodd‐Henricks, K., et al. (2002) · Journal of Neurobiology · doi:10.1002/neu.10173 · Cited by 495 · see citing works

Effect of nicotine and nicotinic receptors on anxiety and depression

Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483 · see citing works

Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery

Holladay, M. W., Dart, M. J., & Lynch, J. K. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970377o · Cited by 442 · see citing works

Psychiatric comorbidity of smoking and nicotine dependence

Breslau, N. (1995) · Behavior Genetics · doi:10.1007/bf02196920 · Cited by 391 · see citing works

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

KENT, J. M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11381-3 · Cited by 329 · see citing works

Clinical Pharmacology of MAO Inhibitors: Safety and Future

Yamada, M. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00097-4 · Cited by 325 · see citing works

Nicotinic acetylcholine receptors as targets for antidepressants

Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279 · see citing works

Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes

Papke, R. L., Sanberg, P. R., & Shytle, R. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29581-1 · Cited by 271 · see citing works

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Pichat, P., Bergis, O., Terranova, J., Urani, A., Duarte, C., Santucci, V., Gueudet, C., Voltz, C., Steinberg, R., Stemmelin, J., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301188 · Cited by 254 · see citing works

The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats

Hajós, M., Hurst, R. S., Hoffmann, W. E., Krause, M., Wall, T. M., Higdon, N. R., & Groppi, V. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076968 · Cited by 225 · see citing works

Antidepressant effects of nicotine in an animal model of depression

Tizabi, Y., Overstreet, D. H., Rezvani, A. H., Louis, V. A., Clark Jr, E., Janowsky, D. S., & Kling, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050879 · Cited by 209 · see citing works

Differentiating antidepressants of the future: Efficacy and safety

Rosenzweig-Lipson, S. J., Beyer, C. E., Hughes, Z. A., Khawaja, X. Z., Rajarao, S. J. R., Malberg, J. E., Rahman, Z. U., Ring, R. H., & Schechter, L. E. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.002 · Cited by 182 · see citing works

Biological Aspects of the Link between Smoking and Depression

Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176 · see citing works

Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function

Fryer, J. D., & Lukas, R. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721117.x · Cited by 137 · see citing works

Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice

Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137 · see citing works

The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice

Rabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129 · see citing works

High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation

Caldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122 · see citing works

Effects of nicotine and mecamylamine on rat dorsal raphe neurons

Mihailescu, S., Palomero-Rivero, M., Meade-Huerta, P., Maza-Flores, A., & Drucker-Colı́n, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00658-x · Cited by 117 · see citing works

Mecamylamine is a selective non-competitive antagonist of and aspartate-induced currents in horizontal cells dissociated from the catfish retina

O’Dell, T. J., & Christensen, B. N. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90276-5 · Cited by 111 · see citing works

TC-1734: An orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects

Gatto, G. J., Bohme, G. A., Caldwell, W. S., Letchworth, S. R., Traina, V. M., Obinu, M. C., Laville, M., Reibaud, M., Pradier, L., Dunbar, G., et al. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00010.x · Cited by 111 · see citing works

CHOLINERGIC REVERSAL OF MANIC SYMPTOMS

Janowsky, D., El‐Yousef, M. K., Davis, J., Hubbard, B. A., & SEKERKE, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90956-7 · Cited by 111 · see citing works

Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial

McClernon, F. J., Hiott, F. B., Westman, E. C., Rose, J. E., & Levin, E. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0516-y · Cited by 106 · see citing works

Induction of Estrus in Grouped Female Mice (Mus domesticus) by Synthetic Analogues of Preputial Gland Constituents

Ma, W. (1999) · Chemical Senses · doi:10.1093/chemse/24.3.289 · Cited by 103 · see citing works

Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release

Kenny, P. J., File, S. E., & Neal, M. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752409.x · Cited by 100 · see citing works

The Association between Depressive Symptoms and Cigarette Smoking in An Urban Primary Care Sample

Brown, C., Madden, P. A. F., Palenchar, D. R., & Cooper, L. A. (2000) · The International Journal of Psychiatry in Medicine · doi:10.2190/ny79-cj0h-vbay-5m1u · Cited by 96 · see citing works

Primer effects by conspecific odors in house mice: a new perspective in the study of primer effects on reproductive activities

小山, 幸. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.03.002 · Cited by 94 · see citing works

Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine

Vázquez-Palacios, G., Bonilla‐Jaime, H., & Velázquez‐Moctezuma, J. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.002 · Cited by 89 · see citing works

Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine

Vázquez-Palacios, G., Bonilla‐Jaime, H., & Velázquez‐Moctezuma, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.008 · Cited by 87 · see citing works

Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression

Ferguson, S. M., Brodkin, J. D., Kenneth Lloyd, G., & Menzaghi, F. (2000) · Psychopharmacology · doi:10.1007/s002130000531 · Cited by 85 · see citing works

Depressive Characteristics of FSL Rats

Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00236-7 · Cited by 70 · see citing works

Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine

Rana, B., McMorn, S. O., Reeve, H. L., Wyatt, C. N., Vaughan, P. F. T., & Peers, C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90388-x · Cited by 57 · see citing works

Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice

Suemaru, K., YASUDA, K., Cui, R., LI, B., Umeda, K., Amano, M., MITSUHASHI, H., TAKEUCHI, N., Inoue, T., & Gomita, Y. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.05.007 · Cited by 44 · see citing works

Mechanism of action of A-85380 in an animal model of depression

Buckley, M. J., Surowy, C. S., Meyer, M., & Curzon, P. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.012 · Cited by 39 · see citing works

Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: Comparison with risperidone

Andreasen, J. T., Andersen, K. K., Nielsen, E. Ø., Mathiasen, L., & Mirza, N. R. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.023 · Cited by 35 · see citing works

Enhancement of Antidepressant-Like Effects but Not Brain-Derived Neurotrophic Factor mRNA Expression by the Novel N-Methyl-d-aspartate Receptor Antagonist Neramexane in Mice

Kos, T., Legutko, B., Danysz, W., Samoriski, G. M., & Popik, P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103697 · Cited by 29 · see citing works

Differential effects of nicotine in inbred and selectively bred rodents

Overstreet, D. H. (1995) · Behavior Genetics · doi:10.1007/bf02196926 · Cited by 27 · see citing works

Cardiac Disorders and Antidepressant Medications

Murray, J. B. (2000) · The Journal of Psychology · doi:10.1080/00223980009600859 · Cited by 26 · see citing works

Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors

García‐Colunga, J., Vázquez-Gómez, E., & Miledi, R. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500275 · Cited by 26 · see citing works

Evidence of reuptake inhibition responsible for mecamylamine-evoked increases in extracellular serotonin

Ma, Z., Pearson, E. J., Isgor, C., & Tao, R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.080 · Cited by 8 · see citing works

Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system

Taly, A., Corringer, P., Guédin, D., Lestage, P. J., & Changeux, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 706 · see citing works

Nicotinic acetylcholine receptors: From basic science to therapeutics

Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 525 · see citing works

Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis

Mineur, Y. S., & Picciotto, M. R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.004 · Cited by 277 · see citing works

Smoking, nicotine and neuropsychiatric disorders

Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works

Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs

Millan, M. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.039 · Cited by 197 · see citing works

Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics

Dulawa, S. C., & Janowsky, D. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0219-x · Cited by 187 · see citing works

Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature

Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1932-6 · Cited by 185 · see citing works

Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint

Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 178 · see citing works

Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment

Ashare, R. L., Falcone, M., & Lerman, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.034 · Cited by 170 · see citing works

Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states

Picciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157 · see citing works

Mechanisms of Nicotine Addiction

Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 157 · see citing works

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

Rollema, H., Hajós, M., Seymour, P. A., Kozak, R., Majchrzak, M. J., Guanowsky, V., Horner, W. E., Chapin, D. S., Hoffmann, W. E., Johnson, D. E., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.033 · Cited by 117 · see citing works

Antidepressant‐like effect of carvacrol (5‐Isopropyl‐2‐methylphenol) in mice: involvement of dopaminergic system

Melo, F. H. C., Moura, B. A., de Sousa, D. P., Vasconcelos, S. M. M., Macêdo, D. S., Fonteles, M. M. D. F., Viana, G. S. D. B., & de Sousa, F. C. F. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00850.x · Cited by 116 · see citing works

Depression‐Related Behavioral Tests

Powell, T. R., Fernandes, C., & Schalkwyk, L. C. (2012) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo110176 · Cited by 114 · see citing works

Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings

Graef, S., Schönknecht, P., Sabri, O., & Hegerl, U. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2153-8 · Cited by 107 · see citing works

The catecholaminergic–cholinergic balance hypothesis of bipolar disorder revisited

van Enkhuizen, J., Janowsky, D. S., Olivier, B., Minassian, A., Perry, W., Young, J. W., & Geyer, M. A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.063 · Cited by 106 · see citing works

Faster, better, stronger: Towards new antidepressant therapeutic strategies

O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 100 · see citing works

Traditional Chinese Formula Xiaoyaosan Alleviates Depressive-Like Behavior in CUMS Mice by Regulating PEBP1-GPX4-Mediated Ferroptosis in the Hippocampus

Jiao, H., Yang, H., Yan, Z., Chen, J., Xu, M., Jiang, Y.-M., Liu, Y., Xue, Z., Ma, Q., Li, X., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s302443 · Cited by 98 · see citing works

Nicotinic acetylcholine receptors in neurological and psychiatric diseases

Terry, A. V., Jones, K., & Bertrand, D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106764 · Cited by 90 · see citing works

Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study

Philip, N. S., Carpenter, L. L., Tyrka, A. R., Whiteley, L. B., & Price, L. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04441 · Cited by 86 · see citing works

Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect

Rollema, H., Guanowsky, V., Mineur, Y. S., Shrikhande, A., Coe, J. W., Seymour, P. A., & Picciotto, M. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.002 · Cited by 87 · see citing works

Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors

Papke, R. L., & Horenstein, N. A. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000097 · Cited by 90 · see citing works

The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action

Wong, E. H. F., Tarazi, F. I., & Shahid, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.001 · Cited by 75 · see citing works

Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression‐like behaviour in C57BL/6J mice

Mineur, Y. S., Mose, T. N., Blakeman, S., & Picciotto, M. R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13769 · Cited by 71 · see citing works

Nicotine addiction and psychiatric disorders

Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65 · see citing works

Activation and Inhibition of Mouse Muscle and Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes

Papke, R. L., Wecker, L., & Stitzel, J. A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164566 · Cited by 67 · see citing works

Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats

Tizabi, Y., Hauser, S. R., Tyler, K. Y., Getachew, B., Madani, R., Sharma, Y., & Manaye, K. F. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.024 · Cited by 63 · see citing works

Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models

Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58 · see citing works

The nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their study

Papke, R. L., Ono, F., Stokes, C. A., Urban, J. M., & Boyd, R. T. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.022 · Cited by 58 · see citing works

Design, Synthesis, and Biological Evaluation of Erythrina Alkaloid Analogues as Neuronal Nicotinic Acetylcholine Receptor Antagonists

Crestey, F., Jensen, A. A., Borch, M., Andreasen, J. T., Andersen, J., Balle, T., & Kristensen, J. L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4013592 · Cited by 57 · see citing works

Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests

Haj‐Mirzaian, A., Kordjazy, N., Haj‐Mirzaian, A., Ostadhadi, S., Ghasemi, M., Amiri, S., Faizi, M., & Dehpour, A. R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4004-0 · Cited by 56 · see citing works

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release

Grady, S. R., Wageman, C. R., Patzlaff, N. E., & Marks, M. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.026 · Cited by 56 · see citing works

Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors

Yu, L.-F., Zhang, H.-K., Caldarone, B. J., Eaton, J. B., Lukas, R. J., & Kozikowski, A. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401937a · Cited by 56 · see citing works

Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters

Aboul‐Fotouh, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3745-5 · Cited by 53 · see citing works

Potential therapeutic uses of mecamylamine and its stereoisomers

Nickell, J. R., Grinevich, V. P., Siripurapu, K. B., Smith, A. M., & Dwoskin, L. P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.005 · Cited by 52 · see citing works

In Alcohol-Dependent Drinkers, What Does the Presence of Nicotine Dependence Tell Us About Psychiatric and Addictive Disorders Comorbidity?

Strat, Y. L., Ramoz, N., & Gorwood, P. A. P. M. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp094 · Cited by 53 · see citing works

Biological basis for the co-morbidity between smoking and mood disorders

Mineur, Y. S., & Picciotto, M. R. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869964 · Cited by 51 · see citing works

α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties

Mineur, Y. S., Einstein, E. B., Seymour, P. A., Coe, J. W., O'Neill, B. T., Rollema, H., & Picciotto, M. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328347546d · Cited by 49 · see citing works

Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action

Andreasen, J. T., Fitzpatrick, C. M., Larsen, M., Skovgaard, L., Nielsen, S. D., Clausen, R. P., Troelsen, K. B., & Pickering, D. S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.001 · Cited by 48 · see citing works

Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests

Andreasen, J. T., & Redrobe, J. P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.016 · Cited by 47 · see citing works

Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380

Caldarone, B. J., Wang, D., Paterson, N. E., Manzano, M., Fedolak, A., Cavino, K., Kwan, M., Hanania, T., Chellappan, S. K., Kozikowski, A. P., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2271-y · Cited by 47 · see citing works

Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: Comparison with sertraline

Andreasen, J. T., Henningsen, K., Bate, S., Christiansen, S., & Wiborg, O. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391831 · Cited by 46 · see citing works

The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development

Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/104105 · Cited by 43 · see citing works

Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: A comparison of SSR180711 and PNU-282987

Andreasen, J. T., Redrobe, J. P., & Nielsen, E. Ø. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.11.004 · Cited by 43 · see citing works

Effects of alpha-7 nicotinic allosteric modulator PNU 120596 on depressive-like behavior after lipopolysaccharide administration in mice

Alzarea, S. I., & Rahman, S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.018 · Cited by 43 · see citing works

Pathophysiology of nAChRs: Limbic circuits and related disorders

Mineur, Y. S., Soares, A. R., Etherington, I. M., Abdulla, Z. I., & Picciotto, M. R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106745 · Cited by 42 · see citing works

Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests

Andreasen, J. T., Gynther, M., Rygaard, A., Bøgelund, T., Nielsen, S. D., Clausen, R. P., Mogensen, J., & Pickering, D. S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.045 · Cited by 41 · see citing works

Low-Dose Ketamine Improves LPS-Induced Depression-like Behavior in Rats by Activating Cholinergic Anti-inflammatory Pathways

Zhao, J., Liu, X., Chang, D., Zhang, X., Lian, H., Du, X., & Gao, L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00669 · Cited by 42 · see citing works

Ketamine-Induced Prefrontal Serotonin Release Is Mediated by Cholinergic Neurons in the Pedunculopontine Tegmental Nucleus

Kinoshita, H., Nishitani, N., Nagai, Y., Andoh, C., Asaoka, N., Kawai, H., Shibui, N., Nagayasu, K., Shirakawa, H., Nakagawa, T., et al. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy007 · Cited by 39 · see citing works

Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test

Andreasen, J. T., Nielsen, E. Ø., Christensen, J. K., Olsen, G. M., Peters, D., Mirza, N. R., & Redrobe, J. P. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110364271 · Cited by 38 · see citing works

Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists

Capelli, A. M., Castelletti, L., Chen, Y. H., Keyl, H. V. D., Pucci, L., Oliosi, B., Salvagno, C., Bertani, B., Gotti, C., Powell, A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01213.x · Cited by 34 · see citing works

Neuropharmacological Potential of Diterpenoid Alkaloids

Salehi, A., Ghanadian, M., Zolfaghari, B., Jassbi, A. R., Fattahian, M., Reisi, P., Csupor, D., Khan, I. A., & Ali, Z. (2023) · Pharmaceuticals · doi:10.3390/ph16050747 · Cited by 30 · see citing works

Nature brings new avenues to the therapy of central nervous system diseases—An overview of possible treatments derived from natural products

Zhang, J., Yang, H., Jiang, X., Jiang, H., & Shen, J. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-9587-y · Cited by 25 · see citing works

Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats

Hall, B. J., Pearson, L. S., & Buccafusco, J. J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.011 · Cited by 26 · see citing works

Synthesis and Pharmacological Evaluation of DHβE Analogues as Neuronal Nicotinic Acetylcholine Receptor Antagonists

Jepsen, T. H., Jensen, A. A., Lund, M. H., Glibstrup, E., & Kristensen, J. L. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500094c · Cited by 24 · see citing works

Cholinergic Receptor Blockade in the VTA Attenuates Cue-Induced Cocaine-Seeking and Reverses the Anxiogenic Effects of Forced Abstinence

Nunes, E. J., Bitner, L. E., Hughley, S. M., Small, K. M., Walton, S. N., Rupprecht, L. E., & Addy, N. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.06.028 · Cited by 23 · see citing works

Nicotine and 17β-estradiol produce an antidepressant-like effect in female ovariectomized rats

Kandi, P., & Hayslett, R. L. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.12.012 · Cited by 24 · see citing works

Antidepressant-Like Effect of the Leaves ofPseudospondias microcarpain Mice: Evidence for the Involvement of the Serotoninergic System, NMDA Receptor Complex, and Nitric Oxide Pathway

Adongo, D. W., Kukuia, K. K. E., Mante, P. K., Ameyaw, E. O., & Woode, E. (2015) · BioMed Research International · doi:10.1155/2015/397943 · Cited by 23 · see citing works

Antidepressant-like effects of lobeline in mice: Behavioral, neurochemical, and neuroendocrine evidence

Roni, M. A., & Rahman, S. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.011 · Cited by 23 · see citing works

Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats

Hlaváčová, N., Li, Y., Pehrson, A. L., Sánchez, C., Bermúdez, I., Csanova, A., Ježová, D., & Franklin, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.008 · Cited by 23 · see citing works

Role of corticotropin-releasing factor in alcohol and nicotine addiction

Simpson, S., Shankar, K., Kimbrough, A., & George, O. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146850 · Cited by 23 · see citing works

Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts

Crestey, F., Jensen, A. A., Soerensen, C., Magnus, C. B., Andreasen, J. T., Peters, G. H. J., & Kristensen, J. L. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01895 · Cited by 22 · see citing works

Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test

Andreasen, J. T., Nielsen, E. Ø., & Redrobe, J. P. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1560-1 · Cited by 21 · see citing works

α7 nicotinic receptor full agonist reverse basolateral amygdala hyperactivity and attenuation of dopaminergic neuron activity in rats exposed to chronic mild stress

Neves, G. A., & Grace, A. A. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.009 · Cited by 22 · see citing works

Phosphatidylethanolamine‐Binding Protein 1 (PEBP1) as a Potential Target for the Treatment for Depression

Sun, Y., Luo, Z., Zheng, M., & Liu, X. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12185 · Cited by 20 · see citing works

Enantioselective Total Synthesis of (+)-Dihydro-β-erythroidine

Clementson, S., Jessing, M., Pedersen, H., Vital, P., & Kristensen, J. L. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b04626 · Cited by 20 · see citing works

The effects of lobeline on depression-like behavior and hippocampal cell proliferation following chronic stress in mice

Roni, M. A., & Rahman, S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.009 · Cited by 19 · see citing works

NAChR α4β2 Subtype and their Relation with Nicotine Addiction, Cognition, Depression and Hyperactivity Disorder

Laikowski, M. M., Reisdorfer, F., & Moura, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180410105135 · Cited by 17 · see citing works

HCNP precursor protein transgenic mice display a depressive-like phenotype in old age

Matsukawa, N., Furuya, Y., Ogura, H., & Ojika, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.041 · Cited by 15 · see citing works

The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial

Davidson, M., Levi, L. W., Park, J., Nastas, I., Ford, L., Rassnick, S., Canuso, C. M., Davis, J. M., & Weiser, M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.020 · Cited by 15 · see citing works

A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances

Andreasen, J. T., Redrobe, J. P., Nielsen, E. Ø., Christensen, J. K., Olsen, G. M., & Peters, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.060 · Cited by 15 · see citing works

Exploring the ameliorative role of α7 neuronal nicotinic acetylcholine receptor modulation in epilepsy and associated comorbidities in post-PTZ-kindled mice

Sharma, N., Kaur, S., & Goel, R. K. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106862 · Cited by 14 · see citing works

Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation

Targowska‐Duda, K. M., Budzyńska, B., Michalak, A., Wnorowski, A., Loland, C. J., Maj, M., Manetti, D., Romanelli, M. N., Jóźwiak, K., Biała, G., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.06.006 · Cited by 14 · see citing works

Different Classes of Antidepressants Inhibit the Rat α7 Nicotinic Acetylcholine Receptor by Interacting within the Ion Channel: A Functional and Structural Study

Duarte, Y., Rojas, M., Canan, J., Pérez, E. G., González-Nilo, F. D., & García‐Colunga, J. (2021) · Molecules · doi:10.3390/molecules26040998 · Cited by 13 · see citing works

Psychiatric Disorders as Vulnerability Factors for Nicotine Addiction: What Have We Learned from Animal Models?

Foll, B. L., Ng, E., Ciano, P. D., & Trigo, J. M. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_6 · Cited by 10 · see citing works

More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder

Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 11 · see citing works

Nicotine intake and problem solving strategies are modified during a cognitively demanding water maze task in rats

Nesil, T., Kanıt, L., & Pöğün, Ş. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.001 · Cited by 9 · see citing works

Blockade of nicotinic acetylcholine receptor enhances the responsiveness to bupropion in the mouse forced swim test

Bağdaş, D., AlSharari, S. D., Roni, M. A., Campbell, V. C., Muldoon, P. P., Carroll, F. I., & Damaj, M. I. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.027 · Cited by 9 · see citing works

α7 nicotinic acetylcholine receptor and depression: Mechanistic insights and therapeutic prospects

Wang, C., Gan, D., Hong, Z., Feng, H., Wu, Y., Xu, G., Xun, T., & Yang, X. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107122 · Cited by 8 · see citing works

Design and Synthesis of Nicotinic Acetylcholine Receptor Antagonists and their Effect on Cognitive Impairment

Poonsawas, P., Boonyarat, C., Arunrungvichian, K., Taylor, P., & Vajragupta, O. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12627 · Cited by 8 · see citing works

Discovery of a Novel Class of Benzimidazole-Based Nicotinic Acetylcholine Receptor Modulators: Positive and Negative Modulation Arising from Overlapping Allosteric Sites

Zhou, L., Dau, V., & Jensen, A. A. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01185 · Cited by 6 · see citing works

Neuromuscular blocking effect of fluoxetine and its interaction with rocuronium

Patel, J. C., Barvaliya, M. J., Patel, T. K., & Tripathi, C. B. (2013) · Autonomic and Autacoid Pharmacology · doi:10.1111/aap.12005 · Cited by 6 · see citing works

Mechanisms of stimulatory effects of mecamylamine on the dorsal raphe neurons

Hernández-González, O., Mondragón-García, A., Hernández‐López, S., Castillo-Rolón, D., Arenas-López, G., Tapia, D., & Mihailescu, S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.031 · Cited by 5 · see citing works

Quantification of methyllycaconitine, selective α7 nicotinic receptor antagonist, in rodent plasma and brain tissue by liquid chromatography tandem mass spectrometry – application to neuropharmacokinetics of methyllycaconitine in rats

Nirogi, R. V. S., Kandikere, V. N., Komarneni, P., Aleti, R. R., Boggavarapu, R. K., Bhyrapuneni, G., Muddana, N., & Mukkanti, K. (2011) · Biomedical Chromatography · doi:10.1002/bmc.1603 · Cited by 5 · see citing works

Erythrina Alkaloid Analogues as nAChR Antagonists–A Flexible Platform for Leads in Drug Discovery

Clementson, S., Matheu, S. A., Märcher-Rørsted, E., Pedersen, H., Jensen, A. A., Clausen, R. P., Vital, P., Glibstrup, E., Jessing, M., & Kristensen, J. L. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c00707 · Cited by 4 · see citing works

An investigation into nicotinic receptor involvement in mood disorders uncovers novel depression candidate genes

Gibbons, A., McPherson, K., Gogos, A., & Dean, B. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.04.007 · Cited by 4 · see citing works

Rapid and Sustained Response to a Single Dose of Sertraline in a Patient with Newly Emergent Depression During Varenicline-Assisted Smoking Cessation

Baran, X. Y., & Docherty, J. P. (2010) · CNS Spectrums · doi:10.1017/s1092852900027401 · Cited by 3 · see citing works

Hexamethonium

Taglialatela, M., & Panza, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.97312-4 · Cited by 2 · see citing works

Novel Therapeutic Strategies for Bipolar Disorder

Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch30

Drug abuse

Steiner, R. C., & Picciotto, M. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.025

Development of Antidepressant Drugs Through Targeting α4β2-Nicotinic Acetylcholine Receptors

Zhang, H., Gunosewoyo, H., Fan, Y., Tang, J., & Yu, L.-F. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_11

Depression

Veljkovic, E., Xia, W., Phillips, B. W., Wong, E. T., Ho, J., Oviedo, A., Hoeng, J., & Peitsch, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812922-7.00007-x

Substance dependence and abuse

Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.024

References

(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812922-7.09994-7

The Effects of Erythrina subumbrans (Hassk.) Merr. Leaves Extract on Nicotine Withdrawal Syndrome and β2 nAChRs Expression in The Ventral Tegmental Area of Rats

Risdiana, N., Susilowati, R., Sholikhah, E. N., & Partadiredja, G. (2022) · BIO Web of Conferences · doi:10.1051/bioconf/20224901002

Function and pharmacology of neuronal nAChRs

Boyd, R. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-819958-9.00002-5

Nodakenin Exhibits Anxiolytic-like and Anti-depressant-like Effects in the Experimental Mice Models

Xu, N., & Zhao, D. (2025) · Pharmacognosy Magazine · doi:10.1177/09731296251348082

Urinary pesticide biomarker associations with depression and anxiety scores from adolescence into young adulthood in the ESPINA cohort

Chronister, B. N. C., Hussari, M. N., López-Paredes, D., Checkoway, H., Suárez-Torres, J., Gahagan, S., Bradman, A., Martínez, D., Hong, S., Moore, R. C., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.04.023

Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence

Bjørklund, G., Gurgas, L., & Hangan, T. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04845-0

Molecular mechanisms of nicotinic acetylcholine receptors in mood dysregulation

Murthy, M. K., & Samal, D. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111880

The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice

Rabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129 · see citing works

Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopram

Popik, P., Kozela, E., & Krawczyk, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705359 · Cited by 74 · see citing works

Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: A comparison of SSR180711 and PNU-282987

Andreasen, J. T., Redrobe, J. P., & Nielsen, E. Ø. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.11.004 · Cited by 43 · see citing works

Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature

Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1932-6 · Cited by 185 · see citing works

S.09.02 Apathy: clinical characterization and neuroimaging findings

Kaiser, S. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.028